Article
Immunization with α-synuclein/Grp94 reshapes peripheral immunity and suppresses microgliosis in a chronic parkinsonism model
Author/s | Villadiego Luque, Francisco Javier
Labrador Garrido, Adahir Franco, Jaime M. Leal Lasarte, Magdalena Genst, Erwin J. de Dobson, Christopher M. Pozo Pérez, David Toledo Aral, Juan José Roodveldt, Cintia |
Department | Universidad de Sevilla. Departamento de Bioquímica Médica y Biología Molecular e Inmunología Universidad de Sevilla. Departamento de Fisiología Médica y Biofísica |
Publication Date | 2018 |
Deposit Date | 2024-01-21 |
Published in |
|
Abstract | Neuroinflammation mediated by chronically activated microglia, largely caused by abnormal accumulation of misfolded α-synuclein (αSyn) protein, is known to contribute to the pathophysiology of Parkinson’s disease (PD). In ... Neuroinflammation mediated by chronically activated microglia, largely caused by abnormal accumulation of misfolded α-synuclein (αSyn) protein, is known to contribute to the pathophysiology of Parkinson’s disease (PD). In this work, based on the immunomodulatory activities displayed by particular heat-shock proteins (HSPs), we tested a novel vaccination strategy that used a combination of αSyn and Grp94 (HSPC4 or Gp96) chaperone and a murine PD model. We used two different procedures, first, the adoptive transfer of splenocytes from αSyn/Grp94-immunized mice to recipient animals, and second, direct immunization with αSyn/Grp94, to study the effects in a chronic mouse MPTP-model of parkinsonism. We found that both approaches promoted a distinct profile in the peripheral system -supported by humoral and cellular immunity- consisting of a Th1-shifted αSyn-specific response accompanied by an immune-regulatory/Th2-skewed general phenotype. Remarkably, this mixed profile sustained by αSyn/Grp94 immunization unexpectedly led to strong suppression of microglial activation in the substantia nigra and striatum, pointing to a newly described beneficial effect of anti-αSyn Th1-responses in the context of PD. This strategy is the first to target αSyn and report the suppression of PD-associated microgliosis. Overall, we show that the αSyn/Grp94 combination supports a distinct and long-lasting immune profile in the peripheral system, which has an impact at the CNS level by suppressing chronic microglial activation in an MPTP model of PD. Furthermore, our study demonstrates that reshaping peripheral immunity by vaccination with appropriate misfolding protein/HSP combinations could be highly beneficial as a treatment for neurodegenerative misfolding diseases. |
Funding agencies | Cambridge Center for Misfolding Diseases European Commission (EC). Fondo Europeo de Desarrollo Regional (FEDER) Instituto de Salud Carlos III Junta de Andalucía Ministerio de Economía. España |
Project ID. | CP10/00527
SAF-2012-39720 RTC-2015-3309-1 PI12/02574-ISCIII RTC-2015-3309-1 RD12/0019/0033 RD16/0011/0025 PI14/01600-ISCIII P12-CTS-2739 P11-CTS8161 CPII16/58 |
Citation | Villadiego Luque, F.J., Labrador Garrido, A., Franco, J.M., Leal Lasarte, M., Genst, E.J.d., Dobson, C.M.,...,Roodveldt, C. (2018). Immunization with α-synuclein/Grp94 reshapes peripheral immunity and suppresses microgliosis in a chronic parkinsonism model. Glia, 66 (1), 191-205. https://doi.org/10.1002/glia.23237. |
Files | Size | Format | View | Description |
---|---|---|---|---|
Immunization with α-synucleinGrp94 ... | 2.744Mb | [PDF] | View/ | Versión aceptada |
This item appears in the following collection(s)
This document is protected by intellectual and industrial property rights. Without prejudice to existing legal exemptions, its reproduction, distribution, public communication or transformation is prohibited without the authorization of the rights holder, unless otherwise indicated.